Cara Therapeutics Inc (CARA) stock is lower by -91.33% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives CARA stock a score of 34 out of a possible 100.
That rank is mainly influenced by a short-term technical score of 3. CARA's rank also includes a long-term technical score of 5.
CARA has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CARA!
Cara Therapeutics Inc (CARA) stock has risen 1.03% while the S&P 500 is lower by -0.04% as of 12:05 PM on Friday, Nov 24. CARA is higher by $0.01 from the previous closing price of $0.96 on volume of 342,522 shares. Over the past year the S&P 500 has risen 13.14% while CARA is lower by -91.33%. CARA lost -$2.16 per share in the over the last 12 months.
Click Here to get the full Stock Report for Cara Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
